[Federal Register Volume 76, Number 149 (Wednesday, August 3, 2011)]
[Notices]
[Pages 46813-46814]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-19614]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-11-11JJ]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of Section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call 404-639-5960 
and send comments to Daniel L. Holcomb, CDC Reports Clearance Officer, 
1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail to 
[email protected].
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Written comments should be received 
within 60 days of this notice.

Proposed Project

    Evaluating Locally-Developed HIV Prevention Interventions for 
African-American MSM in Los Angeles--New--National Center for HIV/AIDS, 
Viral Hepatitis, STD, TB Prevention (NCHHSTP), Centers for Disease 
Control and Prevention (CDC).

Background and Brief Description

    Data reported from 33 states with HIV reporting indicate the burden 
of HIV/AIDS is most concentrated in the African American population 
compared to other racial/ethnic groups. Of the 49,704 African American 
males diagnosed with HIV between 2001 and 2004, 54% of these cases were 
among men who have sex with men (MSM). In Los Angeles County (LAC), the 
proportion of HIV/AIDS cases among African American males attributable 
to male-to-male sexual transmission is

[[Page 46814]]

even greater (75%). In the absence of an effective vaccine, behavioral 
interventions represent one of the few methods for reducing high HIV 
incidence among African American MSM (AAMSM). Unfortunately, in the 
third decade of the epidemic, very few of the available HIV-prevention 
interventions for African American populations have been designed 
specifically for MSM. In fact, until very recently none of CDC's 
evidence-based, HIV-prevention interventions had been specifically 
tested for efficacy in reducing HIV transmission among MSM of color. 
Given the conspicuous absence of (1) Evidence-based HIV interventions 
and (2) outcome evaluations of existing AAMSM interventions, our 
collaborative team intends to address a glaring research gap by 
implementing a best-practices model of comprehensive program 
evaluation.
    The purpose of this project is to test, in a real world setting, 
the efficacy of an HIV transmission prevention intervention for 
reducing sexual risk among African American men who have sex with men 
in LAC. The project is a 3-session, group-level intervention that will 
provide participants with the information, motivation, and skills 
necessary to reduce their risk of transmitting or acquiring HIV. The 
intervention will be evaluated using baseline, 3 month and 6 month 
follow-up assessments. This project will also conduct in-depth 
qualitative interviews with 36 men in order to assess their experiences 
with the intervention, elicit recommendations for improving the 
intervention, and to better understand the factors that put African 
American MSM at risk for HIV.
    CDC is requesting a 3-year clearance for data collection. The data 
collection system involves screenings, limited locator information, 
contact information, a baseline questionnaire, client satisfaction 
surveys, a 3-month follow-up questionnaire, a 6-month follow-up 
questionnaire, and case study interviews. An estimated 700 men will be 
screened for eligibility in order to enroll 528 men. The baseline and 
follow up questionnaires contain questions about participants' socio-
demographic information, health and healthcare, sexual activity, 
substance use, and other psychosocial issues. The duration of each 
baseline, 3-month, and 6-month questionnaires are estimated to be 60 
minutes; the 36 Success Case Study interviews 90 minutes; Outreach 
Recruitment Assessment 5 minutes; limited locator information form 5 
minutes; participant contact information form 10 minutes; each client 
satisfaction survey 5 minutes. There is no cost to participants other 
than their time.

                                                            Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                                         Number        Average burden
              Type of respondent                            Form name                 Number of       responses per    per respondent     Total annual
                                                                                     respondents       respondent        (in hours)      burden in hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
AAMSM.........................................  Outreach Recruitment Assessment                700                 1              5/60                58
                                                 (screener).
AAMSM.........................................  Limited Locator Information.....               700                 1              5/60                58
Enrolled AAMSM................................  Participant Contact Information                528                 1             10/60                88
                                                 Form.
Enrolled AAMSM................................  Baseline Questionnaire..........               528                 1                 1               528
Enrolled AAMSM................................  Client Satisfaction Survey......               224                 3              5/60                56
Enrolled AAMSM................................  3 month follow up Questionnaire.               420                 1                 1               420
Enrolled AAMSM................................  6 month follow up Questionnaire.               400                 1                 1               400
Enrolled AAMSM................................  Success Case Study Interview....                36                 1               1.5                54
                                                                                 -----------------------------------------------------------------------
    Total.....................................  ................................  ................  ................  ................              1662
--------------------------------------------------------------------------------------------------------------------------------------------------------


    Dated: July 27, 2011.
Daniel Holcomb,
Reports Clearance Officer, Centers for Disease Control and Prevention.
[FR Doc. 2011-19614 Filed 8-2-11; 8:45 am]
BILLING CODE 4163-18-P